BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6747307)

  • 1. Comparison of polyethylene glycols as fusogens for producing lymphocyte-myeloma hybrids.
    Lane RD; Crissman RS; Lachman MF
    J Immunol Methods; 1984 Aug; 72(1):71-6. PubMed ID: 6747307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A short-duration polyethylene glycol fusion technique for increasing production of monoclonal antibody-secreting hybridomas.
    Lane RD
    J Immunol Methods; 1985 Aug; 81(2):223-8. PubMed ID: 4020150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal anti-cytokeratin antibody from a hybridoma clone generated by electrofusion.
    Karsten U; Papsdorf G; Roloff G; Stolley P; Abel H; Walther I; Weiss H
    Eur J Cancer Clin Oncol; 1985 Jun; 21(6):733-40. PubMed ID: 2410280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential generation of monoclonal IgG-producing hybridomas by use of vesicular stomatitis virus-mediated cell fusion.
    Nagata S; Yamamoto K; Ueno Y; Kurata T; Chiba J
    Hybridoma; 1991 Jun; 10(3):369-78. PubMed ID: 1655635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison of electric field-mediated and PEG-mediated cell fusion for the generation of antibody producing hybridomas.
    Karsten U; Stolley P; Walther I; Papsdorf G; Weber S; Conrad K; Pasternak L; Kopp J
    Hybridoma; 1988 Dec; 7(6):627-33. PubMed ID: 3235098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved in vitro immunization procedure for the production of monoclonal antibodies.
    Boss BD
    Methods Enzymol; 1986; 121():27-33. PubMed ID: 3724466
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6.
    Harris JF; Hawley RG; Hawley TS; Crawford-Sharpe GC
    J Immunol Methods; 1992 Apr; 148(1-2):199-207. PubMed ID: 1373425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bispecific monoclonal antibodies from hybrid hybridomas.
    Suresh MR; Cuello AC; Milstein C
    Methods Enzymol; 1986; 121():210-28. PubMed ID: 3724461
    [No Abstract]   [Full Text] [Related]  

  • 9. A single-step technique for selecting and cloning hybridomas for monoclonal antibody production.
    Davis JM
    Methods Enzymol; 1986; 121():307-22. PubMed ID: 3487692
    [No Abstract]   [Full Text] [Related]  

  • 10. Production of an ovine monoclonal antibody to testosterone by an interspecies fusion.
    Groves DJ; Morris BA; Tan K; De Silva M; Clayton J
    Hybridoma; 1987 Feb; 6(1):71-6. PubMed ID: 3679254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell growth supplements for promoting the growth of monoclonal antibody-producing hybridoma cells.
    Ransom JH
    Methods Enzymol; 1986; 121():293-5. PubMed ID: 3724467
    [No Abstract]   [Full Text] [Related]  

  • 12. Loss of antibody production accompanied by chromosome loss in a cloned hybrid line secreting antibodies to sheep red blood cells.
    Nowak JS
    Experientia; 1985 Jan; 41(1):88-9. PubMed ID: 3967746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifications of hybridoma technology which improve the yield of monoclonal antibody producing cells.
    Orlik O; Altaner C
    J Immunol Methods; 1988 Nov; 115(1):55-9. PubMed ID: 2848072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the optimal human cell lines for development of human hybridomas.
    Abrams PG; Knost JA; Clarke G; Wilburn S; Oldham RK; Foon KA
    J Immunol; 1983 Sep; 131(3):1201-4. PubMed ID: 6350451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody producing human-human hybridomas. I. Technical aspects.
    Olsson L; Kronstrøm H; Cambon-De Mouzon A; Honsik C; Brodin T; Jakobsen B
    J Immunol Methods; 1983 Jun; 61(1):17-32. PubMed ID: 6343505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in the basic technology of electrofusion for generation of antibody-producing hybridomas.
    Ohnishi K; Chiba J; Goto Y; Tokunaga T
    J Immunol Methods; 1987 Jun; 100(1-2):181-9. PubMed ID: 3110294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production.
    Teng NN; Lam KS; Calvo Riera F; Kaplan HS
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7308-12. PubMed ID: 6316357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell biology of human IgM-producing hybridomas derived from a fusion of human spleen lymphocytes with mouse myeloma cells.
    Jahn S; Grunow R; Kiessig ST; Bogacheva GT; Arsenjeva EL; Hlinak A; Rocklin OV; von Baehr R
    Hybridoma; 1987 Dec; 6(6):679-87. PubMed ID: 3436627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High yields of specific hybridomas obtained by electrofusion of murine lymphocytes immunized in vivo or in vitro.
    van Duijn G; Langedijk JP; de Boer M; Tager JM
    Exp Cell Res; 1989 Aug; 183(2):463-72. PubMed ID: 2767160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyethylene glycol and electric field-mediated cell fusion for formation of hybridomas.
    Karsten U; Stolley P; Seidel B
    Methods Enzymol; 1993; 220():228-38. PubMed ID: 8350756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.